Fig. 6.
Fig. 6. Active MAPKs are required for HS1 and HS2 cell proliferation. / (A) 663 HS1 cells and 606 HS2 cells (B) were treated or not treated with 20 μM of the MEK kinase inhibitor U0126 and/or 10 μM of the PI3K inhibitor LY294002 for the indicated times. The means and standard deviations were determined from 4 experiments.

Active MAPKs are required for HS1 and HS2 cell proliferation.

(A) 663 HS1 cells and 606 HS2 cells (B) were treated or not treated with 20 μM of the MEK kinase inhibitor U0126 and/or 10 μM of the PI3K inhibitor LY294002 for the indicated times. The means and standard deviations were determined from 4 experiments.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal